Bispecific Antibodies - Myeloma's New Frontier | Nishi Shah, MD #myeloma

Bispecific antibodies are transforming the treatment landscape in multiple myeloma. In this HealthTree Roundtable meeting recorded in Atlanta, Nishi Shah, MD, shares insights on how these innovative therapies work, the latest clinical trial data, and what patients and caregivers should know about their potential benefits and challenges.

HealthTree Roundtables are educational events designed to bring myeloma experts and patients together, providing up-to-date information, treatment insights, and answers to patient questions.

Myeloma #BispecificAntibodies #CancerResearch #MultipleMyeloma